Acadia Pharmaceuticals
ACAD
ACAD
330 hedge funds and large institutions have $4.44B invested in Acadia Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 119 increasing their positions, 117 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 117
0% less funds holding
Funds holding: 331 → 330 (-1)
1.09% less ownership
Funds ownership: 99.39% → 98.3% (-1.1%)
Holders
330
Holding in Top 10
6
Calls
$7.66M
Puts
$5.68M
Top Buyers
| 1 | +$45.2M | |
| 2 | +$24.9M | |
| 3 | +$20.3M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$16.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$15.7M |
Top Sellers
| 1 | -$59.1M | |
| 2 | -$44.6M | |
| 3 | -$35.6M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$28.7M |
| 5 |
Millennium Management
New York
|
-$22.2M |
